NB
Non-imaging Biomarkers

Thursday, May 31, 2018: 6:30 PM-7:30 PM
Exhibit Hall A (Nashville Music City Center)
Phosphorylated SIRT1 As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis
Jonathan Ciriello, B.S., University of Maryland School of Medicine; Alexandru Tatomir, M.D., University of Maryland School of Medicine; Daniel Hewes, B.S., University of Maryland School of Medicine; Vinh Nguyen, D.D.S., University of Maryland School of Medicine; Walter Royal III, M.D., Veterans Administration Multiple Sclerosis Center of Excellence; Violeta Rus, M.D., Ph.D., University of Maryland School of Medicine; Horea Rus, M.D., Ph.D., Veterans Administration Multiple Sclerosis Center of Excellence
PDF
Oligoclonal Band Number Correlates with Relapses and Progression in Multiple Sclerosis
Christopher Perrone, MD, University of Pennsylvania; Joseph Berger, MD, University of Pennsylvania; Clyde Markowitz, MD, University of Pennsylvania
PDF
Comparison of an iPAD-Based Visual Assessment and Sloan Letter Acuity Testing in Multiple Sclerosis Patients
Thomas J Shoemaker, MD, Johns Hopkins University School of Medicine; Peter A Calabresi, MD, Johns Hopkins University; Shiv Saidha, MBBCh, Johns Hopkins University; Natalia Gonzalez-Caldito, MD, Johns Hopkins Hospital; Sydney Feldman, BS, Johns Hopkins University; Andrew Aston, BS, Johns Hopkins Hospital; Ohemaa Kwakyi, BS, Johns Hopkins Hospital; Hunter Risher, BS, Johns Hopkins University; Esther Ogboukiri, BS, Johns Hopkins Hospital; Ellen M Mowry, MD, MCR, Johns Hopkins School of Medicine

Impact of Ocrelizumab Treatment on PML Risk Biomarkers
Eric Williamson, MD, University of Pennsylvania; Jakob Dobrowolski, BS, University of Pennsylvania

The Ratio of 1st and 2nd Metatarsal Head Plantar Loading in Individuals with MS and Controls
Cheryl Fields, BS/DO Candidate 2018, Holy Name Medical Center; Anna Srouji, BS, MS, Holy Name Medical Center; Allen Tsai, BS, HSS; Kennedy Abbott, BA, Holy Name Medical Center; Michael A Ciaramella, BA, Hospital for Special Surgery; Rock Positano, DPM, MPH, Hospital for Special Surgery, Rehabilitation-LRMALab; Howard J Hillstrom, PhD, Hospital for Special Surgery; Mary Ann Picone, MD, Holy Name Medical Center
PDF
Relationship Between Skin Tone and Pediatric-Onset Multiple Sclerosis (MS)
Candice L Dunn, BSc, Children's Hospital of Philadelphia; Carmen Yea, MSc, The Hospital for Sick Children; Heather E Hanwell, PhD, Hospital for Sick Children, University of Toronto; E. Ann Yeh, MD, MA, FRCPC, Dip ABPN, The Hospital for Sick Children; Ruth Ann Marrie, MD, PhD, FRCPC, University of Manitoba; Amit Bar-Or, MD, University of Pennsylvania; Neda Ebrahimi, PhD, The Hospital for Sick Children; Brenda Banwell, MD, Children's Hospital of Philadelphia; Julia O'Mahony, BSc, Hospital for Sick Children
PDF
Metabolomic Changes Associated with a Time-Restricted Diet in People with Multiple Sclerosis
Samantha N Roman, B.S., Johns Hopkins University School of Medicine; Kathryn C Fitzgerald, Sc.M., Sc.D., Johns Hopkins University School of Medicine; Ellen M Mowry, MD, MCR, Johns Hopkins School of Medicine

Metabolomic Changes Associated with Calorie Restriction in People with Multiple Sclerosis
Samantha N Roman, B.S., Johns Hopkins University School of Medicine; Kathryn C Fitzgerald, Sc.M., Sc.D., Johns Hopkins University School of Medicine; Ellen M Mowry, MD, MCR, Johns Hopkins School of Medicine

See more of: Poster